Status:
RECRUITING
Tensi+ European Registry
Lead Sponsor:
Stimuli Technology
Conditions:
Overactive Bladder
Eligibility:
All Genders
18+ years
Brief Summary
Tensi+ (Stimuli Technology, Boulogne Billancourt, France) is a newly released, medical transcutaneous-posterior tibial nerve stimulation (TC-pTNS) device marketed for overactive bladder (OAB) manageme...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Patients suffering from idiopathic or neurological overactive bladder
Exclusion
- Patients with pacemaker, defibrillator, or any other electronic implant;
- Patients with metal implant near the stimulation area;
- Pregnant women;
- People suffering from ankle joint problems, swollen ankles or a dermatological condition or damaged skin in the area where the electrodes are to be placed;
- Patient with cognitive impairment;
- Inability to complete a voiding diary;
- No social security cover (for applicable countries).
Key Trial Info
Start Date :
February 27 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
October 1 2027
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT07205445
Start Date
February 27 2025
End Date
October 1 2027
Last Update
October 3 2025
Active Locations (17)
Enter a location and click search to find clinical trials sorted by distance.
1
HFME - Hospices Civils de Lyon
Bron, France, 69500
2
CHU de Rennes
Rennes, France, 35033
3
CHU de Rennes
Rennes, France, 35033
4
CHU de Rouen - Hôpital Charles Nicolle
Rouen, France, 76031